🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Revance Therapeutics, Inc.
Market Cap: Medium
Employees: Medium
Daxibotulinumtoxin A
Revance Therapeutics, Inc. is a biotechnology company focused on developing, manufacturing, and commercializing neuromodulators for various aesthetic and therapeutic indications.
Website
Leadership | About | About | Contact | Contact | About | About | About | Careers | Culture | Benefits | Directors | About | Sustainability | About | News | Events | About | About | About | About
Symbol: RVNC
Recent Price: $3.06
Industry: Biotechnology
CEO: Mr. Mark J. Foley
Sector: Healthcare
Employees: 597
Address: 1222 Demonbreun Street, Nashville, TN 37203
Phone: 615 724 7755
Leadership
- Mark J. Foley, Chief Executive Officer
- Tobin Schilke, Chief Financial Officer
- Erica Jordan, Chief Commercial Officer
- Dwight O. Moxie, Chief Legal Officer and General Counsel
- Amie Krause, Chief People Officer
- David A. Hollander, Chief Medical Officer, Global Therapeutics Franchise Lead
- Angus C. Russell, CHAIRMAN OF THE BOARD, CHAIR, NOMINATING AND GOVERNANCE COMMITTEE
- Chris Nolet, Chair, Audit Committee
- Jill Beraud, CHAIR, BRAND COMMITTEE, COMPENSATION COMMITTEE
- Vlad Coric,
- Julian S. Gangolli,
- Carey O’Connor Kolaja,
- Olivia C. Ware,
Last updated: 2024-12-31